MediFind

Find a Doctor

Erik M. Ohman

Private Diagnostic Clinic PLLC
Cardiology, Internal Medicine
Male
Practicing approx. 39 years

Bio


Erik Ohman is an Internal Medicine specialist and a Cardiologist in Chapel Hill, North Carolina. He has been an author on 359 peer reviewed articles in the past 15 years. Dr. Ohman's top three areas of expertise are Angina, Unstable Angina, and Acute Coronary Syndrome. He is licensed to treat patients in NC.

Contact

300 Meadowmont Village Cir
Suite 311
Chapel Hill, NC 27517, US

Latest Research


Latest Advance
Study
  • Condition: Acute Coronary Syndromes (ACS)
  • Journal: Journal of the American College of Cardiology
  • Treatment Used: With or Without Percutaneous Coronary Intervention (PCI)
  • Number of Patients: 45011
  • Published —
This study assessed the link between post-discharge bleeding and subsequent mortality after acute coronary syndrome (ACS) with or without percutaneous coronary intervention (PCI).
Latest Advance
Study
  • Condition: Acute Coronary Syndrome
  • Journal: Circulation
  • Treatment Used: Prasugrel Versus Ticagrelor Versus Clopidogrel
  • Number of Patients: 52816
  • Published —
In this study, researchers compared the effectiveness of prasugrel versus ticagrelor versus clopidogrel for the treatment of acute coronary syndrome.
Latest Advance
Study
  • Condition: Patients with Stable Coronary Artery Disease (CAD) and Moderate or Severe Left Ventricular Systolic Dysfunction
  • Journal: ESC heart failure
  • Treatment Used: Percutaneous Coronary Intervention (PCI)
  • Number of Patients: 901
  • Published —
This study determined the role of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) and moderate or severe left ventricular systolic dysfunction.
Latest Advance
Study
  • Condition: High-Risk Patients after Percutaneous Coronary Intervention (PCI)
  • Journal: The New England journal of medicine
  • Treatment Used: Ticagrelor with or without Aspirin
  • Number of Patients: 9006
  • Published —
This study examined the effect of ticagrelor alone as compared with ticagrelor plus aspirin with regard to clinically relevant bleeding among patients who were at high risk for bleeding or an ischemic event and had undergone percutaneous coronary intervention (PCI).
Latest Advance
Study
  • Condition: Atrial Fibrillation (AF)
  • Journal: Annual review of medicine
  • Treatment Used: Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)
  • Number of Patients: 0
  • Published —
This article discusses non-vitamin K antagonist oral anticoagulants (NOACs) in the treatment of atrial fibrillation (heart quivering; AF).
Latest Advance
Study
  • Condition: Acute Coronary Syndromes
  • Journal: Coronary artery disease
  • Treatment Used: Early Discontinuation of Prasugrel or Clopidogrel
  • Number of Patients: 1436
  • Published —
This study analyzed patients with acute coronary syndrome who received at least one dose of the study drug and discontinued the drug 7-365 days after randomization, and compared event rates between prasugrel and clopidogrel.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

300 Meadowmont Village Cir
Suite 311
Chapel Hill, NC 27517, US

Affiliations

  • Duke University Hospital

Credentials

  • Licenses
    Internal Medicine in NC
  • Board Certifications
    Interventional Cardiology
    Cardiovascular Disease (Cardiology)
    Internal Medicine

Insurance

Contact them to find out if they accept your insurance plan.